A case of tacrolimus-induced reversible cerebral vasoconstriction syndrome after heart transplantation


Reversible cerebral vasoconstriction syndrome (RCVS) after heart transplantation is a rare, but serious complication, because of a high risk for permanent neurological deficits or allograft rejection. A 48-year-old female who underwent orthotropic heart transplantation presented with a sudden severe headache 10 days after transplantation. Although magnetic resonance angiography (MRA) findings at initial symptom onset were normal, MRA finding at the next day revealed multifocal vasoconstriction of cerebral arteries. Tacrolimus-induced RCVS was strongly suspected, and tacrolimus was immediately discontinued and basiliximab was added as an alternative immunosuppressant. Notably, neurological symptoms occurred at the time of sharp increase in serum tacrolimus levels and resolved when it decreased to low levels. Follow-up MRA showed complete remission and she recovered without any neurological symptom or allograft rejection. Our case suggests that prompt diagnosis with repeated MRA and immediate discontinuation of tacrolimus are essential to avoid severe neurological sequelae of RCVS.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. 1.

    Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11(10):906–17.

    Article  Google Scholar 

  2. 2.

    Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke. 2010;41(11):2505–11.

    Article  Google Scholar 

  3. 3.

    Kodama S, Mano T, Masuzawa A, Hirata Y, Nagasako Y, Mano KK, et al. Tacrolimus-induced reversible cerebral vasoconstriction syndrome with delayed multi-segmental vasoconstriction. J Stroke Cerebrovasc Dis. 2017;26(5):e75–7.

    Article  Google Scholar 

  4. 4.

    Ban SP, Hwang G, Kim CH, Kwon O. Reversible cerebral vasoconstriction syndrome combined with posterior reversible encephalopathy syndrome after heart transplantation. J Clin Neurosci. 2017;42:118–21.

    Article  Google Scholar 

  5. 5.

    Kumai Y, Seguchi O, Sato T, Wada K, Shiozawa M, Yokota C, et al. Reversible cerebral vasoconstriction syndrome after heart transplantation: a case report. Transplant Proc. 2017;49(10):2415–8.

    CAS  Article  Google Scholar 

  6. 6.

    Park CS, Park JJ. Two rare neurologic complications after heart transplantation: posterior reversible encephalopathy syndrome, followed by reversible cerebral vasoconstriction syndrome. J Heart Lung Transplant. 2016;35(7):940–3.

    Article  Google Scholar 

  7. 7.

    Kitamura S. Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg. 2012;60:639–44.

    Article  Google Scholar 

  8. 8.

    Sato M, Okada Y, Oto T, Minami M, Shiraishi T, Nagayasu T, et al. Registry of the Japanese Society of Lung and Heart-Lung Transplantation: official Japanese lung transplantation report. Gen Thorac Cardiovasc Surg. 2014;62:594–601.

    Article  Google Scholar 

  9. 9.

    Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13:313–26.

    CAS  Article  Google Scholar 

  10. 10.

    Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–56.

    Article  Google Scholar 

Download references


No funding was obtained for this study.

Author information



Corresponding author

Correspondence to Yoshiki Sawa.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest existed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Maeda, S., Saito, S., Toda, K. et al. A case of tacrolimus-induced reversible cerebral vasoconstriction syndrome after heart transplantation. Gen Thorac Cardiovasc Surg 68, 1483–1486 (2020). https://doi.org/10.1007/s11748-020-01309-2

Download citation


  • Heart transplantation
  • Neurological complications
  • Immunosuppressant
  • Tacrolimus
  • Vasospasm